170
Views
2
CrossRef citations to date
0
Altmetric
Note

New cytotoxic clerodane diterpenes from the leaves of Premna tomentosa

, , , , , & show all
Pages 215-221 | Received 06 Apr 2015, Accepted 02 Jul 2015, Published online: 21 Oct 2015
 

Abstract

Bio-activity directed investigation of hexane extract from the leaves of Premna tomentosa led to the isolation of three new clerodane diterpenes (13) along with four known compounds (47). The structures of new compounds were established using IR, MS, 1D, and 2D NMR techniques. The in vitro cytotoxicity of the crude hexane extract and the isolated compounds were evaluated against seven human cancer cell lines and results indicated that compounds 2 and 4 depicted significant cytotoxicity against hepatocellular carcinoma cell line.

Acknowledgements

The authors are thankful to Dr M. Lakshmi Kantam, Director, Indian Institute of Chemical Technology, for her constant encouragement and support. This investigation was supported by the financial grant received from CSIR, New Delhi India under CSC 0130 (NaPAHA) project. ND acknowledges the financial assistance provided by ICMR-JRF fellowship. AD acknowledges the financial assistance provided by Ministry of Science & Technology, Govt of India 12th Five Year plan project CSC-0111 (SMilE).

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.